# Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-pd-1-pd-l1-inhibitors-as-first-line-treatment-for/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Wei Ren,Hanyu Zhang,Yixin Li,Wu Sun,Hexiang Peng,Huangda Guo,Tianjiao Hou,Mengying Wang,Zhendong Hu,Tao Wu,Baorui Liu |
| Citations | 10 |
| DOI | 10.3389/fimmu.2025.1563300 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1563300/pdf |
| OpenAlex ID | https://openalex.org/W4408841790 |
| PMID | 40207226 |
| Type | review |
| Year | 2025 |

## Paper authors

- [Tianjiao Hou](https://scholariq.org/researchers/tianjiao-hou/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.